Policy number: SRP 081
Policy name: Platelet Rich Plasma Injections for Tendinopathy
Status: Not Funded
Effective date: 1 April 2024
Next review date: 1 April 2029
Mid and South Essex ICB does not fund Platelet Rich Plasma (autologous blood) Injections for Tendinopathy.
The evidence on autologous blood injection for tendinopathy raises no major safety concerns. However, the evidence on efficacy remains inadequate with few studies available that use appropriate comparators.
This service/procedure has been assessed as a Low Clinical Priority by MSE ICB and will not be funded unless there are exceptional clinical circumstances.
Individual funding requests should only be made where the patient demonstrates clinical exceptionality.
Find out more information on applying for funding in exceptional clinical circumstances
Reference:
Autologous blood injection for tendinopathy
Interventional procedures guidance [IPG438] Published: 23 January 2013